Peripheral arterial disease of the lower extremities
- PMID: 22662015
- PMCID: PMC3361053
- DOI: 10.5114/aoms.2012.28568
Peripheral arterial disease of the lower extremities
Abstract
Persons with peripheral arterial disease (PAD) are at increased risk for all-cause mortality, cardiovascular mortality, and mortality from coronary artery disease. Smoking should be stopped and hypertension, dyslipidemia, diabetes mellitus, and hypothyroidism treated. Statins reduce the incidence of intermittent claudication and improve exercise duration until the onset of intermittent claudication in persons with PAD and hypercholesterolemia. The serum low-density lipoprotein cholesterol should be reduced to < 70 mg/dl. Antiplatelet drugs such as aspirin or clopidogrel, angiotensin-converting enzyme inhibitors, and statins should be given to persons with PAD. β-Blockers should be given if coronary artery disease is present. Cilostazol improves exercise time until intermittent claudication. Exercise rehabilitation programs should be used. Revascularization should be performed if indicated.
Keywords: antiplatelet drugs; exercise; peripheral arterial disease; revascularization; statins.
Similar articles
-
Peripheral arterial disease.Geriatrics. 2007 Jan;62(1):19-25. Geriatrics. 2007. PMID: 17223718 Review.
-
Management of peripheral arterial disease of the lower extremities.Compr Ther. 2007 Winter;33(4):247-56. doi: 10.1007/s12019-007-8013-8. Compr Ther. 2007. PMID: 18025617 Review.
-
Peripheral arterial disease and abdominal aortic aneurysm in elderly people.Minerva Med. 2011 Dec;102(6):483-500. Minerva Med. 2011. PMID: 22193380 Review.
-
Management of peripheral arterial disease of the lower extremities in elderly patients.J Gerontol A Biol Sci Med Sci. 2004 Feb;59(2):172-7. doi: 10.1093/gerona/59.2.m172. J Gerontol A Biol Sci Med Sci. 2004. PMID: 14999033 Review.
-
Peripheral arterial disease in the elderly.Clin Interv Aging. 2007;2(4):645-54. doi: 10.2147/cia.s2412. Clin Interv Aging. 2007. PMID: 18225466 Free PMC article. Review.
Cited by
-
Improvement of hepatic bioavailability as a new step for the future of statin.Arch Med Sci. 2015 Apr 25;11(2):406-10. doi: 10.5114/aoms.2015.50972. Epub 2015 Apr 23. Arch Med Sci. 2015. PMID: 25995759 Free PMC article.
-
Factors associated with diabetic polyneuropathy-related sensory symptoms and signs in patients with polyneuropathy: A cross-sectional Japanese study (JDDM 52) using a non-linear model.J Diabetes Investig. 2020 Mar;11(2):450-457. doi: 10.1111/jdi.13117. Epub 2019 Aug 6. J Diabetes Investig. 2020. PMID: 31314173 Free PMC article.
-
Natural Activators of Autophagy Increase Maximal Walking Distance and Reduce Oxidative Stress in Patients with Peripheral Artery Disease: A Pilot Study.Antioxidants (Basel). 2022 Sep 18;11(9):1836. doi: 10.3390/antiox11091836. Antioxidants (Basel). 2022. PMID: 36139910 Free PMC article.
-
Moderate dose of dietary nitrate improves skeletal muscle microvascular function in patients with peripheral artery disease.Microvasc Res. 2023 Mar;146:104469. doi: 10.1016/j.mvr.2022.104469. Epub 2022 Dec 21. Microvasc Res. 2023. PMID: 36563997 Free PMC article. Clinical Trial.
-
Health Effects of the Programmed Physical Activities on Lipid Profile in Peripheral Arterial Disease of the Lower Extremities.Med Arch. 2015 Oct;69(5):311-4. doi: 10.5455/medarh.2015.69.311-314. Epub 2015 Oct 4. Med Arch. 2015. PMID: 26622083 Free PMC article. Clinical Trial.
References
-
- Dormandy JA, Rutherford RB, the TASC Working Group TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD) J Vasc Surg. 2000;31:1–296. - PubMed
-
- McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease. Associated clinical characteristics and functional impairment. JAMA. 2001;286:1599–606. - PubMed
-
- McDermott MM, Greenland P, Liu K, et al. Sex differences in peripheral arterial disease: leg symptoms and physical functioning. J Am Geriatr Soc. 2003;51:222–8. - PubMed
LinkOut - more resources
Full Text Sources